The digital solution to patient-centred cancer care

Why needed?

Research shows that standard oncology care can significantly benefit from greater active involvement of cancer patients in decisions about their own care, an approach known as patient-centred care. However, due to a lack of implementation methods, patient-centred care has not been integrated into clinical routine to this day.

Funded by the EU’s Horizon Europe programme, the MyPath research project will develop a novel digital solution, MyPath, consisting of electronic patient-centred care pathways – custom-made for each individual patient, including real-time communication of symptoms and care preferences.

The solution will be implemented systematically in cancer care by investigating, improving, and adapting to organisational contexts of cancer centres across Europe. By doing so, MyPath will translate the proven concept of patient-centred care into an integrated practical reality in oncology.

The ambition of MyPath is to establish integrated and efficient patient-centred care that is respectful of, and responsive to, individual patient preferences, needs, and values.

0 M
Cancer centres

Latest news

MyPath at World Cancer Congress 2022

From 18 – 20 October, more than 1,500 cancer experts convened in Geneva to attend the 2022 World Cancer Congress organised by the Union for International Cancer Control (UICC). As...

Read More

MyPath presented at the ESMO congress

Last Friday, September 9, our coordinator Prof. Stein Kaasa (Oslo University Hospital) gave a talk on the MyPath project at the European Society for Medical Oncology (ESMO) congress in Paris,...

Read More

MyPath successfully kicks off in Oslo

On September 1 and 2, the whole consortium came together in Oslo, Norway for the official MyPath kick-off meeting. The event, hosted by the Oslo University Hospital, provided all 36...

Read More

The MyPath consortium aims to develop and implement innovative patient-centred care pathways in a digital solution – applicable to all cancer patients irrespective of treatment intention and stage of disease.

Our solution will empower patients as active partners and lay the groundwork for shared decision-making. Decision support will be an integrated part of the MyPath solution for patients and healthcare providers.

The MyPath solution will be developed and gradually implemented in nine cancer centres across Europe through iterative processes.